Myocardial ischemia induced by prostacyclin and iloprost (original) (raw)
Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion
Giuseppe Ambrosio
American Heart Journal, 1988
View PDFchevron_right
Myocardial ischemia during intravenous prostacyclin administration: Hemodynamic findings and precautionary measures
Daniela Tollemeto
American Heart Journal, 1987
View PDFchevron_right
Iloprost Added to the Cardioplegic Solutions Improves Myocardial Performance
Dogan Yucel
Prostaglandins & Other Lipid Mediators, 1998
View PDFchevron_right
Preservation of myocardial metabolism in acute coronary artery occlusions with retrograde coronary sinus perfusion and iloprost
Ahmet Işcan
Prostaglandins Leukotrienes and Essential Fatty Acids, 1998
View PDFchevron_right
Effects of intravenous prostacyclin in variant angina
Sergio Lorenzo
2010
View PDFchevron_right
Failure of iloprost to protect the regionally ischemic, reperfused porcine heart
Peter Schuff-Werner
Journal of Molecular and Cellular Cardiology, 1991
View PDFchevron_right
Vasorelaxant effect of iloprost on isolated human internal mammary artery
Sule Kalkan
Fundamental & Clinical Pharmacology, 2007
View PDFchevron_right
The in vitro effects of iloprost with other vasodilators on the human internal thoracic artery
kazım beşirli
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2010
View PDFchevron_right
A Retrospective Study of the Effects of Iloprost Infusion on Peripheral Arterial Oxygen Saturation in Patients with Critical Limb Ischemia
Serdar Gunaydin
2015
View PDFchevron_right
Treatment of a case of acute right heart failure by inhalation of iloprost, a long-acting prostacyclin analogue
Olaf Wendler
European Journal of Anaesthesiology, 2001
View PDFchevron_right
Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans
Angelo Gatta, Lorenza Caregaro
Clinical Pharmacology and Therapeutics, 1988
View PDFchevron_right
Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship
Toshio Shimada
International Journal of Cardiology, 1995
View PDFchevron_right
Effects of ischemic preconditioning and iloprost on myocardial ischemia-reperfusion damage in rats
Melike Teker
International journal of clinical and experimental medicine, 2013
View PDFchevron_right
The effects of iloprost on ischemia-reperfusion injury in skeletal muscles in a rodent model
Mustafa Kavutcu
Journal of Surgical Research, 2014
View PDFchevron_right
A Review of the Use of Iloprost, A Synthetic Prostacyclin, in the Prevention of Radiocontrast Nephropathy in Patients Undergoing Coronary Angiography and Intervention
Hayah Kassis
Clinical Cardiology, 2015
View PDFchevron_right
Iloprost for the attenuation of ischaemia/reperfusion injury in a distant organ
Ilhan Mavioglu
Cell Biochemistry and Function, 2006
View PDFchevron_right
Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost
George Cremona
Heart, 1998
View PDFchevron_right
Continuous intravenous infusion of prostaglandin E1 improves myocardial perfusion reserve in patients with ischemic heart disease assessed by positron emission tomography: a pilot study
Kai-Yuan Tzen
Annals of Nuclear Medicine, 2011
View PDFchevron_right
A new method of iloprost administration without a peristaltic pump
Antonio Canton
Current Therapeutic Research, 2000
View PDFchevron_right
Relaxant effect of the prostacyclin analogue iloprost on isolated human radial artery: An approach for the reversal of graft spasm
Ozan Balkanay
Prostaglandins & Other Lipid Mediators, 2017
View PDFchevron_right
Alterations in endocardial vascular resistance after reperfusion in a low flow, high demand model of ischemia: effects of dipyridamole and WEB-2086, a platelet-activating factor antagonist
Erwin Schroeder
Journal of the American College of Cardiology, 1990
View PDFchevron_right
Failure of protective effect of Captopril and Enalapril on exercise and dipyridamole-induced myocardial ischemia
Nicola Ferrara
The American Journal of Cardiology, 1995
View PDFchevron_right
Comparison between iloprost and alprostadil for protection against ischemia/reperfusion injury in a rat model
Hatice Akkaya
TURKISH JOURNAL OF MEDICAL SCIENCES, 2018
View PDFchevron_right
Prostacyclin in experimental myocardial ischemia: Effects on hemodynamics, regional myocardial blood flow, infarct size and mortality
Tedd Brandon
The American Journal of Cardiology, 1981
View PDFchevron_right
Ischemic Postconditioning of the Isolated Human Myocardium: Role of the applied protocol
Carlos Sureda, Kelly Casós
IJC Heart & Vasculature, 2015
View PDFchevron_right
Iloprost and pentoxifylline attenuate ischemia-reperfusion injury in skeletal muscle in rabbit model
Sahin Bozok
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2008
View PDFchevron_right
Ischemic ST-segment changes after dipyridamole infusion
Fred Verzijlbergen
International Journal of Cardiology, 1987
View PDFchevron_right